{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:26:56Z","timestamp":1774124816836,"version":"3.50.1"},"reference-count":117,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.tube.2006.12.006","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T15:26:17Z","timestamp":1172589977000},"page":"257-266","source":"Crossref","is-referenced-by-count":54,"title":["Should a new tuberculosis vaccine be administered intranasally?"],"prefix":"10.1016","volume":"87","author":[{"given":"Gunilla","family":"K\u00e4llenius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Pawlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Brandtzaeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Svenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2006.12.006_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/505877","article-title":"Global incidence of multidrug-resistant tuberculosis","volume":"194","author":"Zignol","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2006.12.006_bib2","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(98)03199-7","article-title":"Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy","volume":"352","author":"Dye","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2006.12.006_bib3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tube.2006.12.006_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0264-410X(98)00277-1","article-title":"A historical and molecular phylogeny of BCG strains","volume":"17","author":"Behr","year":"1999","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.tube.2006.12.006_bib5","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/clinids\/11.Supplement_2.S353","article-title":"The BCG story: lessons from the past and implications for the future","volume":"11","author":"Fine","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.tube.2006.12.006_bib6","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2006.12.006_bib7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(06)70412-1","article-title":"The role of BCG in prevention of leprosy: a meta-analysis","volume":"6","author":"Setia","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2006.12.006_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/CDLI.6.5.675-682.1999","article-title":"Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle","volume":"6","author":"Vordermeier","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.1999.0206","article-title":"Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree","volume":"79","author":"Oettinger","year":"1999","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2006.12.006_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/IAI.44.1.28-32.1984","article-title":"Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria","volume":"44","author":"Orme","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib11","first-page":"553","article-title":"Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis","volume":"94","author":"Palmer","year":"1966","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.tube.2006.12.006_bib12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2006.12.006_bib13","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.4049\/jimmunol.162.11.6843","article-title":"Helminth- and Bacillus Calmette-Gu\u00e9rin-induced immunity in children sensitized in utero to filariasis and schistosomiasis","volume":"162","author":"Malhotra","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib14","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.vaccine.2004.09.038","article-title":"Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis","volume":"23","author":"Elias","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2249.2001.01446.x","article-title":"Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination","volume":"123","author":"Elias","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.coi.2006.05.016","article-title":"Progress in tuberculosis vaccine development","volume":"18","author":"Baumann","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib17","first-page":"151","article-title":"Prospects for new TB vaccines: stop TB working group on TB vaccine development","volume":"8","author":"Fruth","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2006.12.006_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nm0598supp-480","article-title":"Vaccine visions and their global impact","volume":"4","author":"Bloom","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2006.12.006_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1078\/1438-4221-00241","article-title":"Role of secretory antibodies in the defence against infections","volume":"293","author":"Brandtzaeg","year":"2003","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.tube.2006.12.006_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35105075","article-title":"Strategies for designing and optimizing new generation vaccines","volume":"1","author":"Berzofsky","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/IAI.65.1.227-235.1997","article-title":"Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization","volume":"65","author":"Wu","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.it.2004.09.005","article-title":"Let's go mucosal: communication on slippery ground","volume":"25","author":"Brandtzaeg","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib23","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1128\/IAI.66.7.3390-3396.1998","article-title":"Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans","volume":"66","author":"Rudin","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.0105-2896.2005.00283.x","article-title":"Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties","volume":"206","author":"Brandtzaeg","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tube.2006.12.006_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1996.tb21110.x","article-title":"History of oral tolerance and mucosal immunity","volume":"778","author":"Brandtzaeg","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.tube.2006.12.006_bib26","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4049\/jimmunol.170.4.1754","article-title":"Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue","volume":"170","author":"Hagiwara","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-1656(02)00131-1","article-title":"Strategies for designing vaccines eliciting Th1 responses in humans","volume":"98","author":"Moingeon","year":"2002","journal-title":"J Biotechnol"},{"key":"10.1016\/j.tube.2006.12.006_bib28","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0264-410X(02)00091-9","article-title":"In: 2nd meeting on novel adjuvants currently in\/close to human clinical testing. World Health Organization\u2013Organization Mondiale de la Sante Fondation Merieux, Annecy, France, 5\u20137 June 2000","volume":"20","author":"Kenney","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib29","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/S0264-410X(01)00193-1","article-title":"Towards the rational design of Th1 adjuvants","volume":"19","author":"Moingeon","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tube.2006.12.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-409X(01)00176-4","article-title":"Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future","volume":"51","author":"Illum","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tube.2006.12.006_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-409X(01)00170-3","article-title":"Cytokines as adjuvants for the induction of mucosal immunity","volume":"51","author":"Boyaka","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tube.2006.12.006_bib33","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"Freytag","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.0105-2896.2004.0147.x","article-title":"Molecular adjuvants for mucosal immunity","volume":"199","author":"Toka","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tube.2006.12.006_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1567201043334588","article-title":"Mucosal immunisation: adjuvants and delivery systems","volume":"1","author":"Moyle","year":"2004","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.tube.2006.12.006_bib36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1051\/vetres:2006014","article-title":"Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa","volume":"37","author":"Cox","year":"2006","journal-title":"Vet Res"},{"key":"10.1016\/j.tube.2006.12.006_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0264-410X(92)90030-N","article-title":"Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"10","author":"Jertborn","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib38","first-page":"1563","article-title":"Specific antibody-producing cells in humans after oral immunization with a ribosomal vaccine Ribomunyl","volume":"371B","author":"Bene","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.tube.2006.12.006_bib39","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/S0264-410X(03)00077-X","article-title":"Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18\u201336 months of age","volume":"21","author":"Qadri","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CDLI.12.3.447-452.2005","article-title":"Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans","volume":"12","author":"Wassen","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib41","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1128\/JVI.73.9.7780-7786.1999","article-title":"Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers","volume":"73","author":"Gluck","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.tube.2006.12.006_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(00)00171-7","article-title":"Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults","volume":"19","author":"Boyce","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.vaccine.2005.07.088","article-title":"Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects","volume":"24","author":"Treanor","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib44","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1128\/JVI.80.10.4962-4970.2006","article-title":"Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers","volume":"80","author":"Stephenson","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.tube.2006.12.006_bib45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.it.2005.09.012","article-title":"Recent findings in immunology give tuberculosis vaccines a new boost","volume":"26","author":"Kaufmann","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib46","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2006.12.006_bib47","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"Flynn","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2006.12.006_bib48","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1128\/IAI.67.7.3242-3247.1999","article-title":"Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis","volume":"67","author":"Feng","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib49","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/eji.1830251025","article-title":"Protective role of gamma\/delta T cells and alpha\/beta T cells in tuberculosis","volume":"25","author":"Ladel","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2004.02593.x","article-title":"A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab\u2019) fragment prolong survival of mice infected with Mycobacterium tuberculosis","volume":"138","author":"Hamasur","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tube.2006.01.008","article-title":"The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy","volume":"86","author":"Glatman-Freedman","year":"2006","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.tube.2006.12.006_bib52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/368096","article-title":"Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guerin vaccination","volume":"187","author":"Brown","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2006.12.006_bib53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/intimm\/dxl017","article-title":"Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice","volume":"18","author":"Tjarnlund","year":"2006","journal-title":"Int Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib54","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/IAI.70.6.3111-3121.2002","article-title":"Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis","volume":"70","author":"Doherty","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib55","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0264-410X(99)00386-2","article-title":"Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice","volume":"18","author":"Lagranderie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1365-2567.2003.01609.x","article-title":"Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production","volume":"108","author":"Lagranderie","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2006.12.006_bib57","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0264-410X(03)00539-5","article-title":"Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums","volume":"22","author":"Aldwell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/IAI.71.1.101-108.2003","article-title":"Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice","volume":"71","author":"Aldwell","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib60","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.vaccine.2005.01.150","article-title":"Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis","volume":"23","author":"Buddle","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib61","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8T cells within the airway lumen","volume":"174","author":"Santosuosso","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib62","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib63","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2006.01.017","article-title":"Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization","volume":"86","author":"Xing","year":"2006","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.tube.2006.12.006_bib65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clim.2005.11.005","article-title":"Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs","volume":"119","author":"Kawahara","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0192-0561(94)90033-7","article-title":"BCG-induced mucosal immune responses","volume":"16","author":"Gheorghiu","year":"1994","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.tube.2006.12.006_bib67","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Gu\u00e9rin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib68","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/IAI.65.2.623-629.1997","article-title":"Adjuvant modulation of immune responses to tuberculosis subunit vaccines","volume":"65","author":"Lindblad","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib69","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0264-410X(02)00548-0","article-title":"Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs","volume":"21","author":"Hogarth","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.femsim.2005.02.009","article-title":"Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis","volume":"45","author":"Giri","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.tube.2006.12.006_bib71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tube.2004.09.013","article-title":"Nasal boost with adjuvanted heat-killed BCG or arabinomannan\u2013protein conjugate improves primary BCG-induced protection in C57BL\/6 mice","volume":"85","author":"Haile","year":"2005","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.tube.2006.12.006_bib72","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.vaccine.2003.10.016","article-title":"Immunization with heat-killed Mycobacterium bovis Bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis","volume":"22","author":"Haile","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib73","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"Mycobacterium tuberculosis arabinomannan\u2013protein conjugates protect against tuberculosis","volume":"21","author":"Hamasur","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib74","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1016\/j.vaccine.2006.01.060","article-title":"Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-Bacillus Calmette-Gu\u00e9rin in mice","volume":"24","author":"Takahashi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib75","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/IAI.70.7.3681-3688.2002","article-title":"Improved tuberculosis DNA vaccines by formulation in cationic lipids","volume":"70","author":"D\u2019Souza","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib76","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib77","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/IAI.70.3.1443-1452.2002","article-title":"Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice","volume":"70","author":"Jakobsen","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib78","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3346::AID-IMMU3346>3.0.CO;2-P","article-title":"Nasal immune system: distinctive Th0 and Th1\/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively","volume":"28","author":"Hiroi","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib79","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.4049\/jimmunol.167.8.4518","article-title":"The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation","volume":"167","author":"Jones","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib80","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2003.10.020","article-title":"Potent, long lasting systemic antibody levels and mixed Th1\/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles","volume":"22","author":"Carcaboso","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000069012","article-title":"Mucosal tolerance and immunity: regulating the development of allergic disease and asthma","volume":"130","author":"Akbari","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib82","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2249.2004.02618.x","article-title":"The lung cytokine microenvironment influences molecular events in the lymph nodes during Th1 and Th2 respiratory mucosal sensitization to antigen in vivo","volume":"138","author":"Ritz","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib83","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.4049\/jimmunol.176.6.3697","article-title":"The combined CTA1-DD\/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells","volume":"176","author":"Helgeby","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib84","article-title":"The combined CTA1-DD\/ISCOMs vector is an effective intranasal adjuvant for boosting prior BCG immunity to Mycobacterium tuberculosis","author":"Andersen","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib85","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2006.12.006_bib86","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20051782","article-title":"TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis","volume":"202","author":"Bafica","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2006.12.006_bib87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2249.2001.01667.x","article-title":"Intranasal BCG vaccination protects BALB\/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs","volume":"126","author":"Lyadova","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib88","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/S0264-410X(00)00134-1","article-title":"Intranasal vaccination of mice against infection with Mycobacterium tuberculosis","volume":"18","author":"Falero-Diaz","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2005.01.014","article-title":"Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu","volume":"104","author":"Carpenter","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.tube.2006.12.006_bib90","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an Adenovirus-Vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib91","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/79631","article-title":"Is the development of a new tuberculosis vaccine possible?","volume":"6","author":"Kaufmann","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2006.12.006_bib92","doi-asserted-by":"crossref","unstructured":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 1996;348:17\u201324.","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"10.1016\/j.tube.2006.12.006_bib93","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG\u2013REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2006.12.006_bib94","first-page":"536","article-title":"A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil","volume":"10","author":"Dantas","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2006.12.006_bib95","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2223\/JPED.1499","article-title":"BCG vaccine: efficacy and indications for vaccination and revaccination","volume":"82","author":"Barreto","year":"2006","journal-title":"J Pediatr (Rio de Janeiro)"},{"key":"10.1016\/j.tube.2006.12.006_bib96","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/IAI.71.11.6411-6419.2003","article-title":"Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination","volume":"71","author":"Buddle","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib97","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0197-2456(02)00216-7","article-title":"Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age","volume":"23","author":"Barreto","year":"2002","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.tube.2006.12.006_bib98","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2005.07.103","article-title":"Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations","volume":"24","author":"Basaraba","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.12.006_bib99","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2006.12.006_bib100","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.69.4.2714-2717.2001","article-title":"Boosting vaccine for tuberculosis","volume":"69","author":"Brooks","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib101","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1128\/IAI.69.5.3041-3047.2001","article-title":"Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting","volume":"69","author":"Tanghe","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib102","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/IAI.69.6.4174-4176.2001","article-title":"Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis","volume":"69","author":"Feng","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib103","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2006.12.006_bib104","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.tube.2006.12.006_bib105","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs","volume":"72","author":"Brandt","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib106","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib107","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib108","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2567.2004.01903.x","article-title":"Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and Bacille Calmette-Guerin","volume":"112","author":"Vordermeier","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2006.12.006_bib109","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1128\/IAI.71.9.4901-4907.2003","article-title":"A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis","volume":"71","author":"Skinner","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.12.006_bib110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tube.2004.09.015","article-title":"Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials","volume":"85","author":"McShane","year":"2005","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.tube.2006.12.006_bib111","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib112","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0952-7915(02)00384-9","article-title":"Recent advances in mucosal vaccines and adjuvants","volume":"14","author":"Eriksson","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.tube.2006.12.006_bib113","doi-asserted-by":"crossref","unstructured":"Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; in press, doi:10.1016\/j.vaccine.2006.12.001.","DOI":"10.1016\/j.vaccine.2006.12.001"},{"key":"10.1016\/j.tube.2006.12.006_bib114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/156720106776359249","article-title":"Vaccine delivery\u2014current trends and future","volume":"3","author":"Azad","year":"2006","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.tube.2006.12.006_bib115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/17425247.3.1.87","article-title":"Noninvasive delivery technologies: respiratory delivery of vaccines","volume":"3","author":"Sullivan","year":"2006","journal-title":"Exp Opin Drug Deliv"},{"key":"10.1016\/j.tube.2006.12.006_bib116","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/jam.2004.17.249","article-title":"Bi-directional nasal delivery of aerosols can prevent lung deposition","volume":"17","author":"Djupesland","year":"2004","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.tube.2006.12.006_bib117","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/ajrccm.157.1.9703028","article-title":"Effects of systemic and local immunization on alveolar epithelial permeability to protein in the rat","volume":"157","author":"Folkesson","year":"1998","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979207000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979207000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T20:05:35Z","timestamp":1683749135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979207000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1472979207000030"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2006.12.006","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}